Takeda Pharmaceutical Co Ltd

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

5,682,847

Value ($000)

88,596

Weight

0.1%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	88,596	0.1%	5,682,847	12/31/2025
2025 Q3	11/13/2025	41,413	0.0%	2,828,778	9/30/2025
2025 Q2	8/13/2025	18,841	0.0%	1,218,690	6/30/2025
2025 Q1	5/14/2025	20,825	0.0%	1,400,456	3/31/2025
2024 Q4	2/12/2025	55,825	0.0%	4,216,373	12/31/2024
2024 Q3	11/14/2024	459	0.0%	4,635,392	9/30/2024
2024 Q2	8/14/2024	29,963	0.0%	2,315,515	6/30/2024
2024 Q1	5/15/2024	18,959	0.0%	1,364,927	3/31/2024
2023 Q4	2/14/2024	27,230	0.0%	1,908,221	12/31/2023
2023 Q3	11/14/2023	38,271	0.0%	2,473,910	9/30/2023
2023 Q2	8/14/2023	36,670	0.0%	2,334,195	6/30/2023
2023 Q1	5/15/2023	17,424	0.0%	1,057,275	3/31/2023
2022 Q4	2/14/2023	60,907	0.1%	3,904,296	12/31/2022
2022 Q3	11/14/2022	18,665	0.0%	1,439,118	9/30/2022
2022 Q2	8/15/2022	14,505	0.0%	1,033,086	6/30/2022
2022 Q1	5/13/2022	2,316	0.0%	161,713	3/31/2022
2021 Q2	8/13/2021	1,476	0.0%	87,700	6/30/2021
2021 Q1	5/14/2021	4,768	0.0%	261,131	3/31/2021
2020 Q4	2/12/2021	4,207	0.0%	231,178	12/31/2020
2020 Q3	11/12/2020	8,023	0.0%	449,745	9/30/2020
2020 Q2	8/12/2020	9,585	0.0%	534,578	6/30/2020
2020 Q1	5/15/2020	6,300	0.0%	415,001	3/31/2020
2019 Q4	2/13/2020	866	0.0%	43,883	12/31/2019